Retrospective Cohort Study of COVID-19 in Patients of the Brazilian Public Health System with SARS-CoV-2 Omicron Variant Infection

被引:3
|
作者
Murari, Thiago B. [1 ]
Dos Santos Fonseca, Larissa Moraes [1 ,2 ]
Pereira, Hernane B. de B. [1 ,3 ]
Nascimento Filho, Aloisio S. [1 ]
Saba, Hugo [1 ,3 ]
Scorza, Fulvio A. [4 ]
de Almeida, Antonio-Carlos G. [5 ]
Maciel, Ethel L. N. [6 ]
Mendes, Jose F. F. [7 ,8 ]
Rocha Filho, Tarcisio M. [9 ,10 ]
David, John R. [11 ,12 ]
Badaro, Roberto [1 ,2 ]
Souza Machado, Bruna Aparecida [1 ,2 ]
Moret, Marcelo A. [1 ,3 ]
机构
[1] Univ Ctr SENAI CIMATEC, Modelagem Computac, BR-41650010 Salvador, BA, Brazil
[2] Univ Ctr SENAI CIMATEC, SENAI Inst Innovat ISI Hlth Adv Syst, BR-41650010 Salvador, BA, Brazil
[3] Univ Estado Bahia, Dept Ciencias Exatas & Terra, BR-41150000 Salvador, BA, Brazil
[4] Univ Fed Sao Paulo EPM UNIFESP, Escola Paulista Med, Disciplina Neurociencia, BR-04021001 Sao Paulo, SP, Brazil
[5] Univ Fed Sao Joao del Rei UFSJ, Dept Engn Biossistemas, BR-36307352 Sao Joao Del Rei, MG, Brazil
[6] Univ Fed Espirito Santo, Lab Epidemiol, BR-29075910 Vitoria, ES, Brazil
[7] Univ Aveiro, Dept Fis, P-3880 Aveiro, Portugal
[8] Univ Aveiro, I3N, P-3880 Aveiro, Portugal
[9] Univ Brasilia, Int Ctr Condensed Matter Phys, BR-70910900 Brasilia, DF, Brazil
[10] Univ Brasilia, Inst Fis, BR-70910900 Brasilia, DF, Brazil
[11] Harvard TH Chan Sch Publ Hlth, Fac Publ Hlth, Boston, MA 02115 USA
[12] Harvard Med Sch, Dept Immunol & Infect Dis, Boston, MA 02115 USA
关键词
booster; vaccine effectiveness; COVID-19; VACCINATION; IMPACT;
D O I
10.3390/vaccines10091504
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several vaccines against COVID-19 are now available, based on different techniques and made by different laboratories spread around the world. With the roll out of the vaccination process in an advanced stage in many countries, the reduced risk of hospitalization due to the Omicron variant relative to the Delta variant infection, despite the higher transmission risk of Omicron, may lead to a misinterpretation of the results, as infection by Omicron is associated with a significant reduction in severe outcomes and shorter hospitalization time than the Delta variant. We compared the in-hospital mortality due to the Omicron (Jan-Mar 2022) with Gamma (Jan 2021) and Delta (Oct-Dec 2021) variants of patients in the Brazilian public health system. This study also discusses the decrease in booster vaccine effectiveness in patients hospitalized due to the Omicron variant compared with the Delta variant. Without a remodeling of vaccines for new variants, booster doses may be necessary with a shorter time interval.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Post COVID-19 condition of the Omicron variant of SARS-CoV-2
    Morioka, S.
    Tsuzuki, S.
    Suzuki, M.
    Terada, M.
    Akashi, M.
    Osanai, Y.
    Kuge, C.
    Sanada, M.
    Tanaka, K.
    Maruki, T.
    Takahashi, K.
    Saito, S.
    Hayakawa, K.
    Teruya, K.
    Hojo, M.
    Ohmagari, N.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (11) : 1546 - 1551
  • [2] Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study
    Gram, Mie Agermose
    Emborg, Hanne-Dorthe
    Schelde, Astrid Blicher
    Friis, Nikolaj Ulrik
    Nielsen, Katrine Finderup
    Moustsen-Helms, Ida Rask
    Legarth, Rebecca
    Lam, Janni Uyen Hoa
    Chaine, Manon
    Malik, Aisha Zahoor
    Rasmussen, Morten
    Fonager, Jannik
    Sieber, Raphael Niklaus
    Stegger, Marc
    Ethelberg, Steen
    Valentiner-Branth, Palle
    Hansen, Christian Holm
    PLOS MEDICINE, 2022, 19 (09)
  • [3] Properties of the Omicron Variant of SARS-CoV-2 Affect Public Health Measure Effectiveness in the COVID-19 Epidemic
    Furuse, Yuki
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (09)
  • [4] Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2
    Zhang, Jianguo
    Chen, Nan
    Zhao, Daguo
    Zhang, Jinhui
    Hu, Zhenkui
    Tao, Zhimin
    FRONTIERS IN MEDICINE, 2022, 9
  • [5] Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2
    Zhang, Jianguo
    Zhao, Daguo
    Hu, Jianhui
    Huang, Xing
    Gu, Qingqing
    Tao, Zhimin
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [6] Viral dynamics of omicron BA.2.76 variant of SARS-CoV-2 in a cohort of COVID-19 patients
    Li, Kangguo
    Wang, Demeng
    Qu, Huimin
    Rui, Jia
    Abudunaibi, Buasiyamu
    Guo, Zhinan
    Wu, Sihan
    Abudurusuli, Guzainuer
    Yang, Zimei
    Fang, Kang
    Zhang, Yidun
    Su, Chenghao
    Chen, Tianmu
    JOURNAL OF INFECTION, 2023, 86 (02) : 181 - 184
  • [7] Infection with the Omicron variant of SARS-CoV-2 is associated with less severe disease in hospitalized patients with COVID-19
    Aiello, Tommaso Francesco
    Puerta-Alcalde, Pedro
    Chumbita, Mariana
    Monzo, Patricia
    Lopera, Carlos
    Hurtado, Juan Carlos
    Meira, Fernanda
    Mosquera, Mar
    Santos, Marta
    Fernandez-Pittol, Mariana
    Mensa, Josep
    Martinez, Jose Antonio
    Soriano, Alex
    Marcos, Ma Angeles
    Garcia-Vidal, Carolina
    JOURNAL OF INFECTION, 2022, 85 (05) : E152 - E154
  • [8] Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
    Karim, Salim S. Abdool
    Karim, Quarraisha Abdool
    LANCET, 2021, 398 (10317): : 2126 - +
  • [9] Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity
    Joung, Sandy Y.
    Ebinger, Joseph E.
    Sun, Nancy
    Liu, Yunxian
    Wu, Min
    Tang, Amber B.
    Prostko, John C.
    Frias, Edwin C.
    Stewart, James L.
    Sobhani, Kimia
    Cheng, Susan
    JAMA NETWORK OPEN, 2022, 5 (08) : E2227241
  • [10] Effectiveness of Inactivated COVID-19 Vaccines against COVID-19 Caused by the SARS-CoV-2 Delta and Omicron Variants: A Retrospective Cohort Study
    Hua, Qiaoli
    Zheng, Danwen
    Yu, Bo
    Tan, Xinghua
    Chen, Qiumin
    Wang, Longde
    Zhang, Jing
    Liu, Yuntao
    Weng, Heng
    Cai, Yihang
    Xu, Xiaohua
    Feng, Bing
    Zheng, Guangjuan
    Ding, Banghan
    Guo, Jianwen
    Zhang, Zhongde
    VACCINES, 2022, 10 (10)